Towards this goal, blocking antibodies against CD39 or CD73 showed dampened adenosine production by ovarian cancer cell lines and restored cytotoxicity of NK cells and stimulated proliferation of CD4+ T cells in co-culture with ovarian cancer cells [13]. Here, ENTPD1 is linked to ovarian cancer.